Please login or register first to view this content.
Neurologic Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Long-Term Systemic Hormone Therapy May Up Alzheimer Risk
Inbrija Now Available for On-Demand Use for OFF Periods in Patients With Parkinson Disease
Contributors to Delay of Multiple Sclerosis Diagnosis ID’d
FDA to Review Diroximel Fumarate for Treatment of Relapsing Forms of MS
Soliris Gets Priority Review for Rare, Complement-Mediated CNS Disorder
Early Intensive Treatment May Improve Long-Term MS Outcomes
Brief Anesthesia in Infancy Does Not Mar Neurodevelopment
Sports Medicine Society Updates Concussion Guidelines
Energy Drink-Med Interaction Identified as Likely Cause of Patient’s Breakthrough Seizure
FDA Warns Companies to Stop Selling Dietary Supplements That Claim to Treat Alzheimer Disease
NDA for Low-Dose Fenfluramine Submitted for Treatment of Dravet Syndrome
Trazodone Not Associated With Reduced Risk for Dementia
FDA to Review Cenobamate for the Treatment of Partial-Onset Seizures
Antiepileptic Injectable Recalled Due to Product Mislabeling
Investigational Treatment for Multiple System Atrophy Gets Orphan Drug Status
FDA Rejects NDA for Sublingual Film Formulation of Apomorphine
Trials Evaluating Crenezumab in Early Alzheimer Disease Halted
Intensive BP Treatment Does Not Reduce Dementia Risk
